April 1, 2020 / 2:04 AM / 2 months ago

BRIEF-Noxopharm Proposes To Evaluate Idronoxil Use In Patients

April 1 (Reuters) - Noxopharm Ltd:

* PROPOSES TO EVALUATE IDRONOXIL USE IN PATIENTS AT RISK OF ACUTE RESPIRATORY DISTRESS SYNDROME AND MULTI-ORGAN FAILURE DUE TO COVID-19 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below